Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results - Roudier MP, Vesselle H, True LD, Higano CS, Ott SM, King SH, Vessella RL, Department of Urology, University of Washington, Seattle, WA. Clin Exp Metastasis 2003;20:171-180

By Smith J.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 483-483

Elsevier

Access to resources Recommend Favorite

Bone loss and the evolving role of bisphosphonate therapy in prostate cancer

By Higano C.S.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 392-398

Elsevier

Access to resources Recommend Favorite

The Role of Bone Scintigraphy in the Follow-up of Osteogenic Sarcoma

By Korholz D.   Wirtz I.   Vosberg H.   Ruther W.   Jurgens H.   Gobel U.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 461-464

Elsevier

Access to resources Recommend Favorite

Serum follistatin in patients with prostate cancer metastatic to the bone

By Tumminello Francesca   Badalamenti Giuseppe   Fulfaro Fabio   Incorvaia Lorena   Crescimanno Marilena   Flandina Carla   Sepporta Maria   Leto Gaetano  

Clinical and Experimental Metastasis, Vol. 27, Iss. 8, 2010-12 ,pp. : 549-555

Springer Publishing Company

Access to resources Recommend Favorite

Yield of imaging and scintigraphy assessing biochemical failure in prostate cancer patients1

By Johnstone P.A.S.   Tarman G.J.   Riffenburgh R.   Rohde D.C.   Puckett M.L.   Kane C.J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 4, 1997-07 ,pp. : 108-112

Elsevier

Access to resources Recommend Favorite